back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-08-25 19:04 Tx date 2025-08-22 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
31,000 | |
| Filed 2025-08-25 19:03 Tx date 2025-08-21 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,800 vol |
33,500 | |
| Filed 2025-08-25 19:02 Tx date 2025-08-22 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-700 vol |
48,800 | |
| Filed 2025-08-25 19:02 Tx date 2025-08-21 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
49,500 | |
| Filed 2025-08-21 11:32 Tx date 2025-08-20 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
52,000 | |
| Filed 2025-08-21 11:32 Tx date 2025-08-18 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
54,500 | |
| Filed 2025-08-20 14:03 Tx date 2025-08-15 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,400 vol |
36,300 | |
| Filed 2025-08-15 18:22 Tx date 2025-08-13 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
57,000 | |
| Filed 2025-08-15 18:20 Tx date 2025-08-14 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-100 vol |
38,700 | |
| Filed 2025-08-15 18:20 Tx date 2025-08-13 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
38,800 | |
| Filed 2025-08-14 14:36 Tx date 2025-08-12 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
59,500 | |
| Filed 2025-08-14 14:35 Tx date 2025-08-11 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
62,000 | |
| Filed 2025-08-11 19:16 Tx date 2025-08-05 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
40,800 | |
| Filed 2025-08-05 21:38 Tx date 2025-07-30 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-500 vol |
42,800 | |
| Filed 2025-08-01 11:10 Tx date 2025-07-30 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-2,500 vol |
64,500 | |
| Filed 2025-07-11 16:43 Tx date 2025-07-08 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-1,700 vol |
43,300 | |
| Filed 2025-07-11 16:42 Tx date 2025-07-07 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
45,000 | |
| Filed 2025-07-04 16:04 Tx date 2025-07-03 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
50,000 | |
| Filed 2025-07-04 16:04 Tx date 2025-07-02 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
55,000 | |
| Filed 2025-07-04 16:03 Tx date 2025-06-30 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
60,000 | |
| Filed 2025-07-02 20:01 Tx date 2025-06-30 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
67,000 | |
| Filed 2025-07-02 20:01 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-4,000 vol |
77,000 | |
| Filed 2025-05-28 19:39 Tx date 2025-05-28 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-8,800 vol |
65,000 | |
| Filed 2025-05-28 19:39 Tx date 2025-05-27 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-1,200 vol |
73,800 | |
| Filed 2025-05-28 19:38 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-8,000 vol |
75,000 | |
| Filed 2025-05-28 19:36 Tx date 2025-05-28 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
76,000 | |
| Filed 2025-05-28 19:34 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
81,000 | |
| Filed 2025-05-26 17:49 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
25,000 | |
| Filed 2025-05-26 17:49 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
75,000 | |
| Filed 2025-05-26 17:47 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
212,500 | |
| Filed 2025-05-26 17:46 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
37,500 | |
| Filed 2025-05-26 17:44 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
312,500 | |
| Filed 2025-05-26 17:40 Tx date 2025-05-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
187,500 | |
| Filed 2025-05-23 20:14 Tx date 2025-05-23 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
83,000 | |
| Filed 2025-05-23 20:14 Tx date 2025-05-22 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
85,000 | |
| Filed 2025-05-23 20:13 Tx date 2025-05-21 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
90,000 | |
| Filed 2025-05-23 20:11 Tx date 2025-05-23 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
86,000 | |
| Filed 2025-05-23 20:11 Tx date 2025-05-22 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-1,500 vol |
91,000 | |
| Filed 2025-05-23 20:11 Tx date 2025-05-21 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
92,500 | |
| Filed 2025-05-20 16:47 Tx date 2025-05-20 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
95,000 | |
| Filed 2025-05-20 13:52 Tx date 2025-05-20 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
97,500 | |
| Filed 2025-05-09 12:52 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+100,000 vol |
100,000 | |
| Filed 2025-05-09 12:52 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-100,000 vol |
0 | |
| Filed 2025-05-09 12:50 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+100,000 vol |
102,500 | |
| Filed 2025-05-09 12:49 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-100,000 vol |
0 | |
| Filed 2025-05-09 12:48 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+200,000 vol |
205,000 | |
| Filed 2025-05-09 12:47 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-200,000 vol |
45,000 | |
| Filed 2025-05-09 12:43 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+250,000 vol |
275,000 | |
| Filed 2025-05-09 12:42 Tx date 2025-05-09 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-250,000 vol |
225,000 | |
| Filed 2025-03-27 13:29 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
||
| Filed 2025-03-27 13:28 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
||
| Filed 2025-03-27 13:27 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
||
| Filed 2025-03-27 13:27 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
||
| Filed 2025-03-27 13:24 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
||
| Filed 2025-03-27 13:23 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
||
| Filed 2025-03-26 19:47 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
||
| Filed 2025-03-26 19:47 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
||
| Filed 2025-03-26 19:45 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
||
| Filed 2025-03-26 19:44 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
||
| Filed 2025-03-26 19:43 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
||
| Filed 2025-03-26 19:39 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
||
| Filed 2025-03-26 19:47 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
25,000 | |
| Filed 2025-03-26 19:47 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
75,000 | |
| Filed 2025-03-26 19:45 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
12,500 | |
| Filed 2025-03-26 19:44 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
237,500 | |
| Filed 2025-03-26 19:43 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
62,500 | |
| Filed 2025-03-26 19:39 Tx date 2025-03-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
437,500 |